4//SEC Filing
Grossi Federico 4
Accession 0001127602-23-001182
CIK 0001492422other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 7:02 PM ET
Size
4.3 KB
Accession
0001127602-23-001182
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2023-01-05$48.79/sh−2,500$121,975→ 94,884 total
Footnotes (1)
- [F1]This is a scheduled sale from 10b5-1 trading plan.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001720634
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 7:02 PM ET
- Size
- 4.3 KB